Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login
    Users Online: 508
Home Print this page Email this page Small font size Default font size Increase font size
Feedback
Subscribe
 Back To Article

  Reader Comments

Year : 2022 | Volume:  11 | Issue Number:  2

ORIGINAL ARTICLE

Active surveillance of adverse events following the first dose of COVID-19 vaccination – Oxford–AstraZeneca (Covishield) vaccine

Varghese Sangeetha Merrin, John Grace Mary, George Geomcy, Jacob Linda, Paul Mammen, Sachu Arun, Samuel Johnson Abel K, Chandy George Mateethra

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks